Chongqing Women and Children's Health Center   Report issue

Academic/Hospital Phase 4
Founded: Chongqing China (1945)

Organization Overview

First Clinical Trial
2018
NCT04051567
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Chongqing Women and Children's Health Center

Active Ingredients

Drugs in Phase 4 Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fetal Growth Retardation (Phase 4)

Pre-Eclampsia (Phase 4)

Premature Birth (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1